Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3

Abstracts Benign prostate hyperplasia (BPH) is an age-related disease in men characterized by the growth of prostate cells and hyperproliferation of prostate tissue. This condition is closely related to chronic inflammation. In this study, we highlight the therapeutic efficacy of ellagic acid (EA) f...

Full description

Bibliographic Details
Main Authors: Woo Yong Park, Gahee Song, Ja Yeon Park, Kwang Seok Ahn, Hyun Jeong Kwak, Jinbong Park, Jun Hee Lee, Jae-Young Um
Format: Article
Language:English
Published: Nature Publishing Group 2022-06-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-04995-3
_version_ 1811344960734101504
author Woo Yong Park
Gahee Song
Ja Yeon Park
Kwang Seok Ahn
Hyun Jeong Kwak
Jinbong Park
Jun Hee Lee
Jae-Young Um
author_facet Woo Yong Park
Gahee Song
Ja Yeon Park
Kwang Seok Ahn
Hyun Jeong Kwak
Jinbong Park
Jun Hee Lee
Jae-Young Um
author_sort Woo Yong Park
collection DOAJ
description Abstracts Benign prostate hyperplasia (BPH) is an age-related disease in men characterized by the growth of prostate cells and hyperproliferation of prostate tissue. This condition is closely related to chronic inflammation. In this study, we highlight the therapeutic efficacy of ellagic acid (EA) for BPH by focusing on the AR signaling axis and STAT3. To investigate the effect of EA on BPH, we used EA, a phytochemical abundant in fruits and vegetables, to treat testosterone propionate (TP)-induced BPH rats and RWPE-1 human prostate epithelial cells. The EA treatment reduced prostate weight, prostate epithelial thickness, and serum DHT levels in the TP-induced BPH rat model. In addition, EA improved testicular injury by increasing antioxidant enzymes in testis of the BPH rats. EA reduced the protein levels of AR, 5AR2, and PSA. It also induced apoptosis by regulating Bax, Bcl_xL, cytochrome c, caspase 9, and caspase 3 with increasing mitochondrial dynamics. Furthermore, EA reduced the expression of IL-6, TNF-α, and NF-κB, as well as phosphorylation of STAT3 and IκBα. These findings were also confirmed in TP-treated RWPE-1 cells. Overall, our data provide evidence of the role of EA in improving BPH through inhibition of AR and the STAT3 pathway.
first_indexed 2024-04-13T19:55:55Z
format Article
id doaj.art-d5ebaa6d72da4935bccc2d724578829f
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-13T19:55:55Z
publishDate 2022-06-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-d5ebaa6d72da4935bccc2d724578829f2022-12-22T02:32:21ZengNature Publishing GroupCell Death and Disease2041-48892022-06-0113611110.1038/s41419-022-04995-3Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3Woo Yong Park0Gahee Song1Ja Yeon Park2Kwang Seok Ahn3Hyun Jeong Kwak4Jinbong Park5Jun Hee Lee6Jae-Young Um7Department of Science in Korean Medicine, Graduate School, Kyung Hee UniversityDepartment of Science in Korean Medicine, Graduate School, Kyung Hee UniversityDepartment of Science in Korean Medicine, Graduate School, Kyung Hee UniversityDepartment of Science in Korean Medicine, Graduate School, Kyung Hee UniversityDepartment of Life Science, College of Natural Sciences, Kyonggi UniversityDepartment of Pharmacology, College of Korean Medicine, Kyung Hee UniversityDepartment of Sasang Constitutional Medicine, College of Korean Medicine, Kyung Hee UniversityDepartment of Science in Korean Medicine, Graduate School, Kyung Hee UniversityAbstracts Benign prostate hyperplasia (BPH) is an age-related disease in men characterized by the growth of prostate cells and hyperproliferation of prostate tissue. This condition is closely related to chronic inflammation. In this study, we highlight the therapeutic efficacy of ellagic acid (EA) for BPH by focusing on the AR signaling axis and STAT3. To investigate the effect of EA on BPH, we used EA, a phytochemical abundant in fruits and vegetables, to treat testosterone propionate (TP)-induced BPH rats and RWPE-1 human prostate epithelial cells. The EA treatment reduced prostate weight, prostate epithelial thickness, and serum DHT levels in the TP-induced BPH rat model. In addition, EA improved testicular injury by increasing antioxidant enzymes in testis of the BPH rats. EA reduced the protein levels of AR, 5AR2, and PSA. It also induced apoptosis by regulating Bax, Bcl_xL, cytochrome c, caspase 9, and caspase 3 with increasing mitochondrial dynamics. Furthermore, EA reduced the expression of IL-6, TNF-α, and NF-κB, as well as phosphorylation of STAT3 and IκBα. These findings were also confirmed in TP-treated RWPE-1 cells. Overall, our data provide evidence of the role of EA in improving BPH through inhibition of AR and the STAT3 pathway.https://doi.org/10.1038/s41419-022-04995-3
spellingShingle Woo Yong Park
Gahee Song
Ja Yeon Park
Kwang Seok Ahn
Hyun Jeong Kwak
Jinbong Park
Jun Hee Lee
Jae-Young Um
Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
Cell Death and Disease
title Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
title_full Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
title_fullStr Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
title_full_unstemmed Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
title_short Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
title_sort ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and stat3
url https://doi.org/10.1038/s41419-022-04995-3
work_keys_str_mv AT wooyongpark ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT gaheesong ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT jayeonpark ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT kwangseokahn ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT hyunjeongkwak ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT jinbongpark ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT junheelee ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3
AT jaeyoungum ellagicacidimprovesbenignprostatehyperplasiabyregulatingandrogensignalingandstat3